1Department of Allergy, La Paz University Hospital, Madrid, Spain
2Department of Pulmonology, La Paz University Hospital, Madrid, Spain
3La Paz Institute for Health Research (IdiPAZ), Madrid, Spain
4CIBER of Respiratory Diseases (CIBERES), Madrid, Spain
HistoryPublished: 11 January 2024
Accepted: 11 January 2024
Received: 13 October 2023
Chronic eosinophilic pneumonia; severe asthma; mepolizumab; reslizumab; benralizumab.